<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This prospective multicentric register was initiated by the European Forum of <z:hpo ids='HP_0003613'>Antiphospholipid Antibodies</z:hpo> (APL) in 2003 after approval by local ethic committees </plain></SENT>
<SENT sid="1" pm="."><plain>This register allows the investigation of infants after written informed parental consent </plain></SENT>
<SENT sid="2" pm="."><plain>It collects mothers' clinical pattern of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS), course and outcome of pregnancy, treatment and immunological status </plain></SENT>
<SENT sid="3" pm="."><plain>For the babies, clinical and immunological examinations are performed at birth; neurodevelopmental conditions followed up to five years </plain></SENT>
<SENT sid="4" pm="."><plain>A re-evaluation of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), anticardiolipin (ACL) or other antibodies will be done if they are positive at birth to follow their kinetics </plain></SENT>
<SENT sid="5" pm="."><plain>A descriptive and a case control study of babies with versus without APL at birth will be possible after the inclusion of 300 cases </plain></SENT>
</text></document>